Clinical evidence suggests that heightened SERPINA3 levels in individuals with new-onset or exacerbating heart failure correlate with increased mortality rates or unplanned cardiac readmissions, underscoring its prognostic value for heart failure (53). The gene discussed is SERPINA3; the disease is heart failure.